top of page
Will single session Y90 become the standard of care for HCC and oligo-metastatic disease? Tune in to our third installment of Dosimetry University with interventional oncologists Drs. Tyler Sandow, Nima Kokabi, and Kavi Krishnasamy as they share their experiences and best practices in single session Y90 treatment.
00:00 / 01:04
Episode # 3 • 17 Jan 2025
Title
Contributor Tagline Rich Text
Description
Funding Label Rich Text
More from
Disclaimer
bottom of page